Showing results (991-1000 of 1,106) with videos related to

Sort By:
Pageof 111
Proteomics. Clinical Applications|March 6, 2024
A novel micropeptide, Slitharin, exerts cardioprotective effects in myocardial infarctionAhmed G E Ibrahim, Alessandra Ciullo, Shukuro Yamaguchi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 13, 2024
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages eraAlessandra Vergori, Alessandro Cozzi Lepri, Marta Chiuchiarelli, et al.
Recenti Progressi in Medicina|October 27, 2016
[Treating HIV disease: back to the patient?]Enrico Girardi, Antonella d'Arminio Monforte, Laura Camoni, et al.
The Journal of Infectious Diseases|June 7, 2003
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistanceAndrea De Luca, Antonella Cingolani, Simona Di Giambenedetto, et al.
JCI Insight|October 5, 2018
Reverse electrical remodeling in rats with heart failure and preserved ejection fractionJae Hyung Cho, Peter J Kilfoil, Rui Zhang, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Structural atlas of <i>Pakpunavirus</i> P7-1 reveals determinants of virion stability and genome ejectionFenglin Li, Nathan Bellis, Ravi K Lokareddy, et al.
Journal of Molecular and Cellular Cardiology|July 25, 2006
Endothelin-1 induced hypertrophic effect in neonatal rat cardiomyocytes: involvement of Na+/H+ and Na+/Ca2+ exchangersRaúl A Dulce, Cecilia Hurtado, Irene L Ennis, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2025
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatmentsE Matteini, C Pinnetti, F Frondizi, et al.
AIDS (London, England)|August 16, 2001
Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapyA Antinori, F Baldini, E Girardi, et al.
Journal of Neurovirology|February 19, 2025
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-upMarta Chiuchiarelli, Giulia Micheli, Francesco Vladimiro Segala, et al.
Pageof 111